Grant McFadden, Ph.D.

Grant is founder, research advisor, and director at OncoMyx. He is one of the top global leaders in oncolytic viruses with a specialization in pox viruses, including myxoma. The McFadden lab pioneered the field of viral immune subversion (also called “anti-immunology”) and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system.